IDEAYA Biosciences, Inc. IDYA

36.69 (0.05) (0.14%) as of 25 Sep
Market cap
$3.6B
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cash and Short Term Investments
639.39 676.32 525.11 364.83 246.77 283.59 98.96 89.96 13.16
Receivables
— 0.00 0.02 0.21 1.10 1.88 — — —
Other current assets
5.97 — — 5.41 3.12 3.14 2.70 0.71 0.42
Total current assets
666.73 689.71 532.63 370.45 251.00 288.61 101.65 90.67 13.58
Property, Plant, Equpment (Net)
8.22 8.97 6.16 6.51 4.76 4.27 4.64 5.15 3.74
Long-Term Investments
410.30 405.83 107.49 8.32 121.29 0.11 1.53 0.11 0.07
Goodwill and Intangible Assets (Total)
— — — — — — — — 0.00
Long-term assets (Other)
1.02 0.81 0.78 0.21 0.40 0.19 0.12 0.15 0.09
Total non-current assets
442.60 434.38 116.68 17.52 130.35 9.66 11.35 5.87 —
Total Assets
1,109.32 1,124.09 649.32 387.97 381.35 298.27 113.00 96.54 0.00
Accounts Payable
17.58 15.42 6.60 4.28 2.10 0.95 0.71 1.42 0.66
Accrued Expenses
40.89 30.35 18.76 17.00 12.32 8.52 5.02 3.58 —
Current Part of Capital Lease
— — — — — — — — 0.00
Current Part of Taxes to Pay
— — — — — — — — 0.00
Current Revenue (Deferred)
— — — — — — — 0.30 —
Other current liabilities
— — — 8.57 29.04 27.63 0.06 0.11 1.77
Total current liabilities
58.82 46.07 27.10 31.72 45.16 38.64 6.94 5.41 2.43
Non-current Revenue (Deferred)
— — — 5.19 31.19 56.16 — 1.57 0.00
Liabilities (Preferred Stock)
— — — — — — — 138.39 —
Minority Interests
— — — — — — — — 0.00
Non-current Liabilities (Other)
— — — 5.19 31.19 56.17 0.03 0.11 1.49
Total non-current liabilities
27.58 18.87 1.13 6.80 34.67 61.36 5.66 140.08 —
Total liabilities
86.39 64.94 28.23 38.51 79.83 100.00 12.60 145.49 0.00
Additional Paid In Capital
1,757.20 1,681.17 968.89 587.72 478.97 325.25 192.82 1.60 0.00
Preferred Stock (Total)
— — — — — — — — 0.00
Common Stock (Net)
0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Retained Earnings
(736.54) (622.84) (348.36) (235.40) (176.75) (126.99) (92.49) (50.52) (16.17)
Treasury Stock
— — — — — — — — 0.00
Shareholders Equity (Other)
— — — — — — — — 0.00
Common Equity (Total)
1,022.93 1,059.15 621.09 349.46 301.51 198.27 100.40 (48.95) (15.74)
Shareholders Equity (Total)
1,022.93 1,059.15 621.09 349.46 301.51 198.27 100.40 (48.95) 0.00
Shareholders Equity and Liabilities (Total)
1,109.32 1,124.09 649.32 387.97 381.35 298.27 113.00 96.54 0.00
Shares (Common)
87.80 86.50 65.04 48.19 38.53 29.54 20.34 1.34 —
Shareholders Equity (Tangible)
1,022.93 1,059.15 621.09 349.46 301.51 198.27 100.40 (48.95) —
Net Debt
(639.39) (676.32) (525.11) (364.83) (246.77) (283.58) (98.96) (89.96) (13.16)
Total Debt
— — — 3.48 5.18 6.72 6.77 — 3.21

Fold the line items

In millions of $ except per-share values · columns are period end dates